|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J. Biol. Chem., Vol. 278, Issue 25, 23085-23093, June 20, 2003
The Alternatively Spliced
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
D. Markovic, H. Lehnert, M. A. Levine, and D. K. Grammatopoulos Structural Determinants Critical for Localization and Signaling within the Seventh Transmembrane Domain of the Type 1 Corticotropin Releasing Hormone Receptor: Lessons from the Receptor Variant R1d Mol. Endocrinol., November 1, 2008; 22(11): 2505 - 2519. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. G. Harikumar, D. I. Pinon, and L. J. Miller Transmembrane Segment IV Contributes a Functionally Important Interface for Oligomerization of the Class II G Protein-coupled Secretin Receptor J. Biol. Chem., October 19, 2007; 282(42): 30363 - 30372. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Q. Davies, G.-W. Chang, S. Yona, S. Gordon, M. Stacey, and H.-H. Lin The Role of Receptor Oligomerization in Modulating the Expression and Function of Leukocyte Adhesion-G Protein-coupled Receptors J. Biol. Chem., September 14, 2007; 282(37): 27343 - 27353. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. W. Hillhouse and D. K. Grammatopoulos The Molecular Mechanisms Underlying the Regulation of the Biological Activity of Corticotropin-Releasing Hormone Receptors: Implications for Physiology and Pathophysiology Endocr. Rev., May 1, 2006; 27(3): 260 - 286. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Bakker, A. F. Lozada, A. van Marle, F. C. Shenton, G. Drutel, K. Karlstedt, M. Hoffmann, M. Lintunen, Y. Yamamoto, R. M. van Rijn, et al. Discovery of Naturally Occurring Splice Variants of the Rat Histamine H3 Receptor That Act as Dominant-Negative Isoforms Mol. Pharmacol., April 1, 2006; 69(4): 1194 - 1206. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. G. Harikumar, M. M. Morfis, C. S. Lisenbee, P. M. Sexton, and L. J. Miller Constitutive Formation of Oligomeric Complexes between Family B G Protein-Coupled Vasoactive Intestinal Polypeptide and Secretin Receptors Mol. Pharmacol., January 1, 2006; 69(1): 363 - 373. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Seck, M. Pellegrini, A. M. Florea, V. Grignoux, R. Baron, D. F. Mierke, and W. C. Horne The {Delta}e13 Isoform of the Calcitonin Receptor Forms a Six-Transmembrane Domain Receptor with Dominant-Negative Effects on Receptor Surface Expression and Signaling Mol. Endocrinol., August 1, 2005; 19(8): 2132 - 2144. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Chen, M. H. Perrin, M. R. DiGruccio, J. M. Vaughan, B. K. Brar, C. M. Arias, K. A. Lewis, J. E. Rivier, P. E. Sawchenko, and W. W. Vale A soluble mouse brain splice variant of type 2{alpha} corticotropin-releasing factor (CRF) receptor binds ligands and modulates their activity PNAS, February 15, 2005; 102(7): 2620 - 2625. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Sarmiento, C. C. Anazco, D. M. Campos, G. N. Prado, J. Navarro, and C. B. Gonzalez Novel Down-regulatory Mechanism of the Surface Expression of the Vasopressin V2 Receptor by an Alternative Splice Receptor Variant J. Biol. Chem., November 5, 2004; 279(45): 47017 - 47023. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |